Matthias Calamia

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Advanced Non Small Cell Lung Cancer

Chronic Lymphocytic Leukemia

Prognostic Factors

Ejection Fraction

Top Venues

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Ivo Abraham, Matthias Calamia, Nimer S Alkhatib, Marc Pondel, Karen M MacDonald
Budget impact analysis of the novel PD-1 inhibitor toripalimab versus pembrolizumab in recurrent or metastatic nasopharyngeal carcinoma. Journal of medical economics 27 (sup3) (2024)
Ivo Abraham, Matthias Calamia, Nimer S Alkhatib, Marc Pondel, Karen M MacDonald
Budget impact analysis of the novel PD-1 inhibitor toripalimab versus pembrolizumab in recurrent or metastatic nasopharyngeal carcinoma. Journal of medical economics (2024)
Briana M Choi, Rachel B Abraham, Hala Halawah, Matthias Calamia, Mavis Obeng-Kusi, Neda Alrawashdh, Daniel Arku, Ivo Abraham
Comparing jurisdiction-specific pharmaco-economic evaluations using medical purchasing power parities. Journal of medical economics 24 (sup1) (2021)
Matthias Calamia, Ali McBride, Ivo Abraham
Economic evaluation of polatuzumab-bendamustine-rituximab vs. tafasitamab-lenalidomide in transplant-ineligible R/R DLBCL. Journal of medical economics 24 (sup1) (2021)